CS
IDYA icon

Credit Suisse’s IDEAYA Biosciences IDYA Stock Holding History

Credit Suisse’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.42M Buy
77,935
+15,325
+24% +$659K ﹤0.01% 1522
2023
Q4 		$2.23M Buy
62,610
+405
+0.7% +$12.1K ﹤0.01% 1815
2023
Q3 		$1.68M Sell
62,205
-7,986
-11% -$203K ﹤0.01% 1933
2023
Q2 		$1.65M Buy
70,191
+35,476
+102% +$729K ﹤0.01% 2060
2023
Q1 		$477K Buy
34,715
+9
+0% +$150 ﹤0.01% 2773
2022
Q4 		$631K Buy
34,706
+14,494
+72% +$244K ﹤0.01% 2634
2022
Q3 		$301K Buy
20,212
+194
+1% +$2.52K ﹤0.01% 3081
2022
Q2 		$276K Sell
20,018
-399
-2% -$4.44K ﹤0.01% 3204
2022
Q1 		$229K Buy
20,417
+1,238
+6% +$18.2K ﹤0.01% 3335
2021
Q4 		$454K Buy
+19,179
New +$446K ﹤0.01% 3886

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Credit Suisse's IDYA Position: Q1 2024 in Review

Credit Suisse increased its IDEAYA Biosciences (IDYA) stake by 24% in Q1 2024, buying an estimated $659K and bringing the position to 77,935 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Credit Suisse first reported a position in IDYA in Q4 2021 and has held it in 10 quarters since. 204 funds tracked by Wall St. Rank hold IDYA as of Q1 2024.

  • Credit Suisse held 77,935 shares of IDEAYA Biosciences worth $3.42M as of Q1 2024.
  • Credit Suisse bought 15,325 IDEAYA Biosciences shares in Q1 2024, an estimated $659K.
  • IDEAYA Biosciences made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1522 holding.
  • Credit Suisse first reported a position in IDEAYA Biosciences in Q4 2021 and has held it in 10 quarters since.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.